Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer (NSCLC)

Explore clinical trials studying Non-small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

145 public trials 47 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer (NSCLC) trial results

Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

NCT07566052

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Oncura Health d.b.a.Los Angeles Cancer Network Glendale, California, United States
  • Astera Cancer Care Edison, New Jersey, United States
  • Virginia Cancer Specialists Arlington, Virginia, United States
  • Hokkaido University Hospital Sapporo, Hokkaido, Japan
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

NCT07288177

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Compassionate Cancer Care Center Fountain Valley, California, United States
  • Providence Medical Foundation (St. Joseph Heritage Healthcare) Santa Rosa, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 41 locations
View Trial Details
Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

NCT07291037

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Chandler, Arizona, United States
  • Research Site Gilbert, Arizona, United States
  • Research Site Goodyear, Arizona, United States
  • Research Site Duarte, California, United States
View all 205 locations
View Trial Details
Recruiting

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

NCT07140016

Conditions
Anaplastic Lymphoma Kinase (ALK) Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Providence Medical Foundation - Fullerton - Virginia K. Crosson Cancer Center Fullerton, California, United States
  • University of California - Irvine Orange, California, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • OSF Health Care Peoria, Illinois, United States
View all 16 locations
View Trial Details
Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

NCT05176483

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
Locations
  • Exelixis Clinical Site #67 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Tucson, Arizona, United States
  • Exelixis Clinical Site #123 Palo Alto, California, United States
  • Exelixis Clinical Site #59 Santa Barbara, California, United States
View all 122 locations
View Trial Details
Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

NCT07540572

Conditions
Brain Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Florida Clinical Trials Group Plantation, Florida, United States
  • START Astera, LLC East Brunswick, New Jersey, United States
  • START New York Long Island, LLC Lake Success, New York, United States
  • NEXT Texas LLC - Austin Austin, Texas, United States
View Trial Details
Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06040541

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Smilow Cancer Hospital (Yale University) New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Lee Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details

Related conditions